Vitamin D binding protein polymorphysm in patients with acute coronary syndrome in kaliningrad region

BACKGROUND: Vitamin D binding protein is a main vitamin D carrier in serum. It also has an impact on macrophagial function. Role of vitamin D and macrophages in the pathogenesis of atherosclerosis is scientifically proven but there is lack of data on vitamin D binding protein in this regard.

AIMS: To evaluate the vitamin D binding protein polymorphism in patients with acute coronary syndrome without diabetes mellitus, autoimmune diseases and malignant tumors. Determine correlation, if there is, between vitamin D binding protein allele and features of acute coronary syndrome among this patient group.

MATERIALS AND METHODS: It is a cross-sectional observational study. Study subjects are patients with acute coronary syndrome. Exclusion criteria are the presence of diabetes mellitus, autoimmune diseases and malignant tumors. In all participants were evaluated: predisposing factors for heart diseases, CBC, biochemical blood test, troponin, coronarography, echocardiography. The study lasted for 5 months from November 2017 until March 2018. Primary end point – assessment of vitamin D binding protein polymorphysm in this group of patients with acute coronary syndrome by means of vitamin D binding protein gene sequencing. 50 patients were enrolled into this study who were urgently admitted to hospital and diagnosed with acute coronary syndrome. Among them – 36 males and 14 females. Mean age was 60 (55;66) years. All participants were sequenced for single nucleotide polymorphysm in VDBP p.T436K (rs4588) and P.432E (rs7041).

RESULTS: Gene polymorphysms of interest were found in 43 patients among 50 enrolled. Haplotype Gc1s/2 (rs7041G-rs4588A) was found in 7 (14%) patients, Gc2 (rs7041T-rs4588A) — in 9 (18%) patients, Gc1s (rs7041G-rs4588C) – in 20 (40%) patients, Gc1f (rs7041T-rs4588C) in 14 (28%). Coronarography showed that coronary artery occlusions obstructing more than 50% of vessel lumen was found in 16 patients; obstruction greater than 90% was seen in 8 patients; total occlusion – in 4 patients.

CONCLUSIONS: In patient group with acute coronary syndrome prevalence of vitamin D binding protein gene polymorphysm was high – in 86% of participants. The features of Gc2 haplotype were higher frequency of recurrent myocardial infarction and total coronary artery occlusion, as well as tendency to decreased serum vitamin D3 (25(OH)D) levels.

vitamin D binding protein, acute coronary syndrome, vitamin D binding protein polymorphysm, vitamin D, atherosclerosis

1. Hutchinson MS, Grimnes G, Joakimsen RM, et al. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol. 2010;162(5):935-942. DOI:10.1530/EJE-09-1041

2. Liu L, Chen M, Hankins SR, et al. Serum 25-Hydroxyvitamin D Concentration and Mortality from Heart Failure and Cardiovascular Disease, and Premature Mortality from All-Cause in United States Adults. Am J Cardiol. 2012;110(6):834-839. DOI:10.1016/j.amjcard.2012.05.013

3. de Boer IH. Serum 25-Hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-Based Population of Older Adults. Ann Intern Med. 2012;156(9):627. DOI:10.7326/0003-4819-156-9-201205010-00004

4. Kestenbaum B, Katz R, de Boer I, et al. Vitamin D, Parathyroid Hormone, and Cardiovascular Events Among Older Adults. J Am Coll Cardiol. 2011;58(14):1433-1441. DOI:10.1016/j.jacc.2011.03.069

5. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population. Arch Intern Med. 2008;168(15):1629-1637. DOI:10.1001/archinte.168.15.1629

6. Dobnig H. Independent Association of Low Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels With All-Cause and Cardiovascular Mortality. Arch Intern Med. 2008;168(12):1340-1349. DOI:10.1001/archinte.168.12.1340

7. Robinson-Cohen C, Hoofnagle AN, Ix JH, et al. Racial Differences in the Association of Serum 25-Hydroxyvitamin D Concentration With Coronary Heart Disease Events. JAMA. 2013;310(2):179. DOI:10.1001/jama.2013.7228

8. Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci. 2018;132(12):1243-1252. DOI:10.1042/CS20180306

9. Agrawal D, Yin K. Vitamin D and inflammatory diseases. J Inflamm Res. May 2014:69. DOI:10.2147/JIR.S63898

10. Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of Vitamin D in Atherosclerosis. Circulation. 2013;128(23):2517-2531. DOI:10.1161/CIRCULATIONAHA.113.002654

11. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003;88(2):327-331. DOI:10.1002/jcb.10343

12. Bikle DD, Siiteri PK, Ryzen E, et al. Serum Protein Binding of 1,25-Dihydroxyvitamin D: A Reevaluation by Direct Measurement of Free Metabolite Levels*. J Clin Endocrinol Metab. 1985;61(5):969-975. DOI:10.1210/jcem-61-5-969

13. Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999;103(2):239-251. DOI:10.1172/JCI5244

14. Bikle DD, Gee E. Free, and Not Total, 1,25-Dihydroxyvitamin D Regulates 25-Hydroxyvitamin D Metabolism by Keratinocytes. Endocrinology. 1989;124(2):649-654. DOI:10.1210/endo-124-2-649

15. Mc Leod JF, Kowalski MA, Haddad JG. Interactions among serum vitamin D binding protein, monomeric actin, profilin, and profilactin. J Biol Chem. 1989;264(2):1260-1267. PMID: 2910852

16. Williams MH, Van Alstyne EL, Galbraith RM. Evidence of a novel association of unsaturated fatty acids with Gc (Vitamin D-binding protein). Biochem Biophys Res Commun. 1988;153(3):1019-1024. DOI:10.1016/S0006-291X(88)81330-5

17. Nagasawa H, Uto Y, Sasaki H, et al. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res. 2005;25(6A):3689-3695. PMID: 16302727

18. Wood AM, Bassford C, Webster D, et al. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax. 2011;66(3):205-210. DOI:10.1136/thx.2010.140921

19. Martineau AR, Leandro ACCS, Anderson ST, et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J. 2010;35(5):1106-1112. DOI:10.1183/09031936.00087009

20. Cleve H, Constans J. The Mutants of the Vitamin-D-Binding Protein: More than 120 Variants of the GC/DBP System. Vox Sang. 1988;54(4):215-225. DOI:10.1111/j.1423-0410.1988.tb03908.x

21. Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet. 1993;92(2). DOI:10.1007/BF00219689

22. Пигарова Е.А., Рожинская Л.Я., Белая Ж.Е., и др. Клинические рекомендации Российской ассоциации эндокринологов по диагностике, лечению и профилактике дефицита витамина D у взрослых // Проблемы Эндокринологии. - 2016. - Т. 62. - №4. - C. 60-84. [Pigarova EA, Rozhinskaya LY, Belaya JE, et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016.62(4):60-84. DOI:10.14341/probl201662460-84

23. Serce Pehlevan O, Karatekin G, Koksal V, et al. Association of vitamin D binding protein polymorphisms with bronchopulmonary dysplasia: a case–control study of gc globulin and bronchopulmonary dysplasia. J Perinatol. 2015;35(9):763-767. DOI:10.1038/jp.2015.58

24. Ishii T, Keicho N, Teramoto S, et al. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J. 2001;18(5):753-757. DOI:10.1183/09031936.01.00094401

25. Santos BR, Lecke SB, Spritzer PM. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study. PLoS One. 2017;12(3):e0173695. DOI:10.1371/journal.pone.0173695

26. Daffara V, Verdoia M, Rolla R, et al. Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease. Nutr Metab Cardiovasc Dis. 2017;27(9):775-783. DOI:10.1016/j.numecd.2017.06.002

27. Skaaby T, Thuesen BH, Linneberg A. Vitamin D, Cardiovascular Disease and Risk Factors. In: Pharmacopsychiatry. Vol 52. Drug Discovery. Cambridge: Royal Society of Chemistry; 2017:221-230. DOI:10.1007/978-3-319-56017-5_18

28. Holmberg S, Rignell-Hydbom A, H Lindh C, et al. High levels of vitamin D associated with less ischemic heart disease – a nested case-control study among rural men in Sweden. Ann Agric Environ Med. 2017;24(2):288-293. DOI:10.5604/12321966.1235176

29. Welles CC, Whooley MA, Karumanchi SA, et al. Vitamin D Deficiency and Cardiovascular Events in Patients With Coronary Heart Disease: Data From the Heart and Soul Study. Am J Epidemiol. 2014;179(11):1279-1287. DOI:10.1093/aje/kwu059

30. Zhou J-C, Zhu Y, Gong C, et al. The GC2 haplotype of the vitamin D binding protein is a risk factor for a low plasma 25-hydroxyvitamin D concentration in a Han Chinese population. Nutr Metab (Lond). 2019;16(1):5. DOI:10.1186/s12986-019-0332-0